Website & contact details
- Website
Mestag Therapeutics Ltd
- Incorporated
- 17 February 2020 (6 years)
- Previously known as
- Biotech 3 Ltd (until 27 March 2020)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Victor SandorPhilip Christopher Astley-SparkeDiana Bernstein
- Owned by
- Johnson & Johnson
- Accounts type
- Small
- Region
- East of England
- Address
- Suites 15 & 16Science Village Chesterford Research ParkLittle ChesterfordSaffron WaldenCB10 1XL
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 1 March 2027
- Last conf. stmt
- 15 February 2026
Charges
- Total
- 2
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 2
Officers 9 active
Officer details are public data from the Companies House register.
Sandor, Victor, Dr
Director · Appointed 13 October 2026
American
Born August 1966 (60)
Astley-Sparke, Philip Christopher
Director · Appointed 6 October 2026
American,British
Born July 1971 (55)
Bernstein, Diana, Dr
Director · Appointed 9 December 2022
American
Born October 1986 (40)
Logtenberg, Ton, Professor
Director · Appointed 8 February 2022
Dutch
Born July 1958 (68)
Rozen, Issi
Director · Appointed 16 July 2021
American
Born April 1967 (59)
Director · Appointed 28 January 2021
British
Born April 1971 (55)
British
Born April 1960 (66)
Director · Appointed 17 April 2020
British
Born October 1965 (61)
Hill, Susan, Dr
Director · Appointed 17 April 2020
British
Born March 1974 (52)
Officer history (9 former)
13 October 2026
Appointed Sandor, Victor, Dr as Director
6 October 2026
Appointed Astley-Sparke, Philip Christopher as Director
6 October 2026
Resigned Van Osch, Martinus Adrianus as Director
22 September 2026
Resigned Dunn, Charles as Director
2 June 2025
Appointed Van Osch, Martinus Adrianus as Director
2 June 2025
Resigned Boulanger Piette, Antoine, Dr as Director
29 February 2024
Resigned Audet, Juliette as Director
29 February 2024
Appointed Boulanger Piette, Antoine, Dr as Director
29 June 2023
Appointed Dunn, Charles as Director
29 June 2023
9 December 2022
Appointed Bernstein, Diana, Dr as Director
9 December 2022
Resigned Gandhi, Shaan-Chirag Chandrahas as Director
8 February 2022
Appointed Logtenberg, Ton, Professor as Director
16 July 2021
Appointed Rozen, Issi as Director
16 July 2021
Appointed Audet, Juliette as Director
16 July 2021
Appointed Gandhi, Shaan-Chirag Chandrahas as Director
31 May 2021
28 January 2021
3 June 2020
3 June 2020
17 April 2020
17 April 2020
17 April 2020
Appointed Hill, Susan, Dr as Director
17 April 2020
17 April 2020
Resigned Dines, Jonathan Alan as Director
17 February 2020
17 February 2020
Appointed Dines, Jonathan Alan as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Johnson & Johnson
Corporate entity · Notified 14 October 2024
Owns 25–50% of shares
Public Company
Former controllers (1)
16 July 2021
Ceased SV7 (Imf) GP LLP — Owns 75–100% of shares
What Mestag Therapeutics say about themselves
“Driving fibroblast-immune conversations in cancer and inflammatory diseases.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 21 October 2026 | Appointment of a director | |||
| 21 October 2026 | Appointment of a director | |||
| 21 October 2026 | Termination of appointment of a director |
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →